Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials

OBJECTIVES: To investigate the safety and immunogenicity of boosting BCG with modified vaccinia Ankara expressing antigen 85A (MVA85A), shortly after BCG vaccination, and to compare this first with the immunogenicity of BCG vaccination alone and second with a previous clinical trial where MVA85A was...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pathan, Ansar A., Sander, Clare R., Fletcher, Helen A., Poulton, Ian, Alder, Nicola C., Beveridge, Natalie E. R., Whelan, Kathryn T., Hill, Adrian V. S., McShane, Helen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2007
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2034536/
https://ncbi.nlm.nih.gov/pubmed/17957238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0001052
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak